Total Funding
39
41
Total FundingDebt Financing raised
Growth Score 39 in past quarter
-1 pts
Heat Score 41 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
75500
Norlase is an ophthalmic laser manufacturer specializing in laser technology for the treatment of retinal and glaucoma disorders.
- Peter Andersen: Co-founder
David Hardwick: Chairman & Co- FounderPast Role: IMRA America, Consultant
About the Company
Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase offers innovative ophthalmic laser solutions, including ECHO and LEAF. ECHO, recognized as the world's first truly portable pattern laser, is battery-powered and equipped with a
wireless user interface featuring voice control capabilities. Its design eliminates the need for fiber tethers, enhancing both portability and treatment flexibility. Meanwhile, LEAF is an ultra-compact green laser photocoagulator that attaches directly to existing slit lamps, streamlining laser treatments by removing the need for external fibers or additional equipment.